Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adenosine deaminase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | adenosine deaminase | 0.0104 | 1 | 0.5 |
Plasmodium vivax | adenosine deaminase, putative | 0.0104 | 1 | 0.5 |
Schistosoma mansoni | adenosine deaminase | 0.0104 | 1 | 0.5 |
Echinococcus multilocularis | adenosine deaminase | 0.0104 | 1 | 1 |
Entamoeba histolytica | adenosine deaminase, putative | 0.0104 | 1 | 0.5 |
Entamoeba histolytica | adenosine deaminase, putative | 0.0104 | 1 | 0.5 |
Mycobacterium leprae | Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) | 0.0104 | 1 | 0.5 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0104 | 1 | 0.5 |
Onchocerca volvulus | Adenosine deaminase homolog | 0.0104 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable adenosine deaminase Add (adenosine aminohydrolase) | 0.0104 | 1 | 1 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0104 | 1 | 0.5 |
Mycobacterium ulcerans | adenosine deaminase | 0.0104 | 1 | 1 |
Treponema pallidum | adenosine deaminase | 0.0104 | 1 | 1 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0104 | 1 | 0.5 |
Leishmania major | adenine aminohydrolase | 0.0104 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0104 | 1 | 1 |
Schistosoma mansoni | adenosine deaminase-related | 0.0104 | 1 | 0.5 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0104 | 1 | 0.5 |
Chlamydia trachomatis | arginine ABC transporter substrate-binding protein ArtJ | 0.004 | 0 | 0.5 |
Echinococcus granulosus | adenosine deaminase | 0.0104 | 1 | 1 |
Chlamydia trachomatis | glutamine binding protein | 0.004 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.